1
|
Kalisvaart M, Broadhurst D, Marcon F, Pande R, Schlegel A, Sutcliffe R, Marudanayagam R, Mirza D, Chatzizacharias N, Abradelo M, Muiesan P, Isaac J, Ma YT, McConville C, Roberts K. Recurrence patterns of pancreatic cancer after pancreatoduodenectomy: systematic review and a single-centre retrospective study. HPB (Oxford) 2020; 22:1240-1249. [PMID: 32046922 DOI: 10.1016/j.hpb.2020.01.005] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2019] [Revised: 11/29/2019] [Accepted: 01/06/2020] [Indexed: 02/06/2023]
Abstract
BACKGROUND Positive margins in pancreatoduodenectomy (PD) for pancreatic cancer, specifically the superior mesenteric artery (SMA) margin, are associated with worse outcomes. Local therapies targeting these margins could impact on recurrence. This study analysed recurrence-patterns to identify whether strategies to control local disease could have a meaningful impact. METHODS (I) Systematic review to define recurrence patterns and resection margin status. (II) Additional retrospective study of PD performed at our centre. RESULTS In the systematic review, 23/617 evaluated studies were included (n = 3815). Local recurrence was observed in 7-69%. SMA margin (6 studies) was positive in 15-35%. In the retrospective study (n = 204), local recurrence was more frequently observed with a positive SMA margin (66 vs.45%; p = 0.005). Furthermore, in a multivariate cox-proportional hazard model, only a positive SMA margin was associated with disease recurrence (HR 1.615; 95%CI 1.127-2.315; p = 0.009). Interestingly, median overall survival was 20 months and similar for patients who developed local only, metastases only or simultaneous recurrence (p = 0.124). CONCLUSION Local recurrence of pancreatic cancer is common and associated with similar mortality rates as those who present with simultaneous or metastatic recurrence. Involvement of the SMA margin is an independent predictor for disease progression and should be the target of future adjuvant local therapies.
Collapse
Affiliation(s)
- Marit Kalisvaart
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Damian Broadhurst
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Francesca Marcon
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Rupaly Pande
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Andrea Schlegel
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Robert Sutcliffe
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Ravi Marudanayagam
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Darius Mirza
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Nikolaos Chatzizacharias
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Manuel Abradelo
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Paolo Muiesan
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - John Isaac
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK
| | - Yuk T Ma
- Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
| | - Christopher McConville
- School of Pharmacy, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, UK
| | - Keith Roberts
- Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
| |
Collapse
|
2
|
Xu M, Wang M, Zhu F, Tian R, Shi CJ, Wang X, Shen M, Qin RY. A new approach for Roux-en-Y reconstruction after pancreaticoduodenectomy. Hepatobiliary Pancreat Dis Int 2014; 13:649-53. [PMID: 25475869 DOI: 10.1016/s1499-3872(14)60047-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
BACKGROUND Postoperative pancreatic fistula remains the most common complication of pancreaticoduodenectomy (PD) and is potentially lethal. It contributes significantly to prolonged hospitalization and mortality. In this study, we introduced a new technical approach, a modified Roux-en-Y reconstruction and evaluated its safety and feasibility. METHODS We retrospectively reviewed the patients who had undergone PD with the modified Roux-en-Y reconstructive technique for periampullary malignancies from January 2011 to June 2012. The data on complications, hospital stay and outcomes after the modified Roux-en-Y reconstruction were analyzed. RESULTS The reconstruction was performed in 171 patients, of whom 92 received pancreaticogastrostomy and 79 received pancreaticojejunostomy. The median duration of surgery was 4.0 hours (range 3.1-6.9) in all patients, and the median blood loss was 530 mL (range 200-2000). Sixty-nine patients were subjected to transfusions, with a median transfusion volume of 430 mL (range 200-1400). The median hospital stay of the patients was 14 days (range 11-38). Their operative mortality was zero and overall morbidity was 18.1% (31 patients). Only four patients (2.3%) developed pancreatic fistulas (grade A fistulas in two patients and grade B in two patients); no patients developed grade C fistula. None of the patients developed bile reflux gastritis. CONCLUSIONS The modified Roux-en-Y reconstruction, which isolates biliary anastomosis from pancreatic, gastric or jejunal anastomosis, is a safe, reliable, and favorable technique. But it needs further investigation in randomized controlled trials.
Collapse
Affiliation(s)
- Meng Xu
- Department of Pancreatic-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
| | | | | | | | | | | | | | | |
Collapse
|
3
|
Jia CK, Lu XF, Yang QZ, Weng J, Chen YK, Fu Y. Pancreaticojejunostomy, hepaticojejunostomy and double Roux-en-Y digestive tract reconstruction for benign pancreatic diseases. World J Gastroenterol 2014; 20:13200-13204. [PMID: 25278718 PMCID: PMC4177503 DOI: 10.3748/wjg.v20.i36.13200] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2014] [Revised: 05/09/2014] [Accepted: 06/13/2014] [Indexed: 02/06/2023] Open
Abstract
Surgery such as digestive tract reconstruction is usually required for pancreatic trauma and severe pancreatitis as well as malignant pancreatic lesions. The most common digestive tract reconstruction techniques (e.g., Child’s type reconstruction) for neoplastic diseases of the pancreatic head often encompass pancreaticojejunostomy, choledochojejunostomy and then gastrojejunostomy with pancreaticoduodenectomy, whereas these techniques may not be applicable in benign pancreatic diseases due to an integrated stomach and duodenum in these patients. In benign pancreatic diseases, the aforementioned reconstruction will not only increase the distance between the pancreaticojejunostomy and choledochojejunostomy, but also the risks of traction, twisting and angularity of the jejunal loop. In addition, postoperative complications such as mixed fistula are refractory and life-threatening after common reconstruction procedures. We here introduce a novel pancreaticojejunostomy, hepaticojejunostomy and double Roux-en-Y digestive tract reconstruction in two cases of benign pancreatic disease, thus decreasing not only the distance between the pancreaticojejunostomy and choledochojejunostomy, but also the possibility of postoperative complications compared to common reconstruction methods. Postoperatively, the recovery of these patients was uneventful and complications such as bile leakage, pancreatic leakage and digestive tract obstruction were not observed during the follow-up period.
Collapse
|
4
|
Wang M, Zhu F, Wang X, Tian R, Shi C, Shen M, Xu M, Han J, Luo N, Qin R. A Modified Technique of End-to-End Pancreaticojejunostomy With Transpancreatic Interlocking Mattress Sutures. J Surg Oncol 2013; 107:783-788. [DOI: 10.1002/jso.23319] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023]
|
5
|
Du FT, Ding W, Lin HF, Gong XX, Li S, Song QH. Invaginated Pancreaticojejunostomy via the Space Behind the Root of Superior Mesenteric Vessels. Gastroenterology Res 2011; 4:64-69. [PMID: 27942316 PMCID: PMC5139756 DOI: 10.4021/gr311e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 03/21/2011] [Indexed: 11/10/2022] Open
Abstract
Background This study was to explore a safe and effective procedure to prevent pancreatic fistula (PF) after pancreaticoduodenectomy (PD). Methods Forty-three modified PD with pancreaticojejunostomy by direct invagination of the pancreas to the jejunum that was brought up via the space behind the root of superior mesenteric vessel were performed between January 2003 and June 2006, and were compared to the fifty-six conventional PD (Child’ method). Results There was no pancreatic fistula after PD in the modified group. Two cases developed biliary fistula that were successfully treated with complete drainage for 2 to 3 weeks; 2 cases abdominal infection managed with anti-infection and completely drainage; 4 cases stress ulcer cured with Losec and coagulant. Three cases in the Child group developed PF of different severities, with amylase level > 9000 U/L in the abdominal drainage fluid. Two of the PF were treated with Stilamin, parenteral nutrition, fasting and completely drainage and cured after 21 to 32 days. The other 82-year-old patient died. Other complications had no significant difference between the two groups (P > 0.05). Conclusions The modified PD can effectively prevent PF and is a safe and effective procedure for periampullary neoplasm. Further studies of its clinical use are warranted.
Collapse
Affiliation(s)
- Fu Tian Du
- Department of Hepatobiliary Surgery, Weifang People's Hospital, Weifang 261041, China
| | - Wei Ding
- Department of Hepatobiliary Surgery, Weifang People's Hospital, Weifang 261041, China
| | - Hong Feng Lin
- Department of Hepatobiliary Surgery, Weifang People's Hospital, Weifang 261041, China
| | - Xiao Xia Gong
- Department of Hepatobiliary Surgery, Weifang People's Hospital, Weifang 261041, China
| | - Sen Li
- Department of Hepatobiliary Surgery, Weifang People's Hospital, Weifang 261041, China
| | - Qin Hua Song
- Department of Hepatobiliary Surgery, Weifang People's Hospital, Weifang 261041, China
| |
Collapse
|
6
|
Shukla PJ, Sakpal SV. Extended pancreatectomy for pancreatic cancers. Indian J Surg 2009; 71:2-5. [DOI: 10.1007/s12262-008-0076-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2008] [Accepted: 10/26/2008] [Indexed: 11/30/2022] Open
|
7
|
Quality of Life of Patients Following Pylorus-Sparing Pancreatoduodenectomy. POLISH JOURNAL OF SURGERY 2008. [DOI: 10.2478/v10035-008-0047-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
8
|
Foss CA, Fox JJ, Feldmann G, Maitra A, Iacobuzio-Donohue C, Kern SE, Hruban R, Pomper MG. Radiolabeled Anti-Claudin 4 and Anti-Prostate Stem Cell Antigen: Initial Imaging in Experimental Models of Pancreatic Cancer. Mol Imaging 2007. [DOI: 10.2310/7290.2007.00010] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Affiliation(s)
- Catherine A. Foss
- From the Departments of Radiology, Pathology, and Oncology, and the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD
| | - James J. Fox
- From the Departments of Radiology, Pathology, and Oncology, and the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD
| | - Georg Feldmann
- From the Departments of Radiology, Pathology, and Oncology, and the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD
| | - Anirban Maitra
- From the Departments of Radiology, Pathology, and Oncology, and the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD
| | - Christine Iacobuzio-Donohue
- From the Departments of Radiology, Pathology, and Oncology, and the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD
| | - Scott E. Kern
- From the Departments of Radiology, Pathology, and Oncology, and the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD
| | - Ralph Hruban
- From the Departments of Radiology, Pathology, and Oncology, and the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD
| | - Martin G. Pomper
- From the Departments of Radiology, Pathology, and Oncology, and the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD
| |
Collapse
|